These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33843686)

  • 1. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
    J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease.
    Thomas AJ; Hamilton CA; Barker S; Durcan R; Lawley S; Barnett N; Firbank M; Roberts G; Allan LM; O'Brien J; Taylor JP; Donaghy PC
    Int Psychogeriatr; 2022 Jun; 34(6):585-592. PubMed ID: 34666863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    Wang Q; Chen B; Zhong X; Zhou H; Zhang M; Mai N; Wu Z; Huang X; Haehner A; Chen X; Auber LA; Peng Q; Hummel T; Ning Y
    J Alzheimers Dis; 2021; 79(2):585-595. PubMed ID: 33361601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Odor Discrimination as a Marker of Early Alzheimer's Disease.
    Audronyte E; Pakulaite-Kazliene G; Sutnikiene V; Kaubrys G
    J Alzheimers Dis; 2023; 94(3):1169-1178. PubMed ID: 37355894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease.
    Audronyte E; Sutnikiene V; Pakulaite-Kazliene G; Kaubrys G
    Med Sci Monit; 2023 May; 29():e940363. PubMed ID: 37243326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
    Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
    J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory function in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
    Jung HJ; Shin IS; Lee JE
    Laryngoscope; 2019 Feb; 129(2):362-369. PubMed ID: 30565695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning Analysis of Digital Clock Drawing Test Performance for Differential Classification of Mild Cognitive Impairment Subtypes Versus Alzheimer's Disease.
    Binaco R; Calzaretto N; Epifano J; McGuire S; Umer M; Emrani S; Wasserman V; Libon DJ; Polikar R
    J Int Neuropsychol Soc; 2020 Aug; 26(7):690-700. PubMed ID: 32200771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.
    Vasavada MM; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
    J Alzheimers Dis; 2015; 45(3):947-58. PubMed ID: 25633674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1.
    Servello A; Fioretti A; Gualdi G; Di Biasi C; Pittalis A; Sollaku S; Pavaci S; Tortorella F; Fusetti M; Valenti M; Masedu F; Cacciafesta M; Marigliano V; Ettorre E; Pagliarella M
    J Alzheimers Dis; 2015; 48(2):395-402. PubMed ID: 26402003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Stable and Scalable Digital Composite Neurocognitive Test for Early Dementia Screening Based on Machine Learning: Model Development and Validation Study.
    Gu D; Lv X; Shi C; Zhang T; Liu S; Fan Z; Tu L; Zhang M; Zhang N; Chen L; Wang Z; Wang J; Zhang Y; Li H; Wang L; Zhu J; Zheng Y; Wang H; Yu X;
    J Med Internet Res; 2023 Dec; 25():e49147. PubMed ID: 38039074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    Massetti N; Russo M; Franciotti R; Nardini D; Mandolini GM; Granzotto A; Bomba M; Delli Pizzi S; Mosca A; Scherer R; Onofrj M; Sensi SL; ;
    J Alzheimers Dis; 2022; 85(4):1639-1655. PubMed ID: 34958014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.